Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial
Go back to Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial| Edwards Lifesciences (NYSE: EW) | Delayed: 87.36 +0.68 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.68 | 52 Week High | $166.87 | |||
| Open | $86.96 | 52 Week Low | $72.20 | |||
| Day High | $87.83 | P/E | 25.40 | |||
| Day Low | $86.52 | EPS | $3.44 | |||
| Volume | 5,550,645 | |||||
